The Global Tumor Ablation Market is Anticipated to Reach $2.16 Billion by 2025, Expanding at a CAGR of 11.12%

world news, trump, u.s., business news, stock market, entertainment news, business news, company news, market, commodities, commodity, Africa news

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]

SOURCE Research and Markets

DUBLIN, Nov 9, 2018 /PRNewswire/ —

The “Tumor Ablation Market Size, Share & Trends Analysis Report By Treatment (Surgical, Laparoscopic), By Technology (Radiofrequency, Microwave, Cryoablation), By Application, And Segment Forecasts, 2018 – 2025” report has been added to’s offering.

Research and Markets Logo

The global tumor ablation market size is anticipated to reach USD 2.16 billion by 2025. It is expected to expand at a CAGR of 11.12% over the forecast period.

High prevalence of cancer across the globe is the key market driver. About 13% of population suffers from cancer each year, as per the statistics by the World Health Organization (WHO). Extensive adoption of minimally invasive procedures due to the benefits such as less trauma, speedy recovery, and faster recovery is anticipated to bode well for market expansion.

Increasing demand for minimally invasive surgeries coupled with technological advancements in thermal ablation is anticipated to boost market growth. For instance, Usage of cooled radiofrequency denervation technique-a procedure that uses radiofrequency thermal energy to ablate sensory nerve fibers of the sacroiliac joint-with internally cooled radiofrequency probes to enlarge size of the lesion. Similarly, in February 2015, SonaCare Medical LLC launched Sonalink-a remote patient monitoring platform-that can be used during HIFU procedures.

In addition, rising per capita income is enabling people to opt for advanced treatment for tumors. This factor is anticipated to positively influence market growth over the forecast period. Active role of healthcare agencies and government in creating awareness about various cancer types is expected to facilitate usage of tumor ablation therapy.

Further key findings from the study suggest:

  • Radiofrequency emerged as the dominant technology segment with 30.5% share in 2016 attributed to application in removal of solid tumors
  • Percutaneous procedures are expected to witness lucrative growth over the forecast period due to rising demand for minimally invasive procedures offering faster recovery and higher safety
  • Lung cancer is anticipated to witness substantial growth owing to high prevalence caused by sedentary lifestyle, rise in smoking, and air pollution
  • North America dominated the overall market in the past due to high prevalence of cancer in Canada, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
  • Major players operating in the tumor ablation market include, Galil Medical Inc.; Misonix Inc.; HealthTronics, Angiodynamics; Boston Scientific Corporation; Medtronic Plc. (Covidien); SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical Inc

Topics Covered

Chapter 1 Executive Summary

Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Data Analysis
2.3 Region Wise Market Calculation
2.3.1 Region Wise Market: Base Estimates
2.3.2 Global Market: CAGR Calculation
2.4 Region based segment share calculation
2.5 List of Secondary Sources (partial list)
2.6 Market Snapshot

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Rising incidence of cancer
3.2.2 Technological advancements in ablation devices
3.2.3 Increasing per capita income
3.2.4 Growing demand of minimally invasive surgeries
3.3 Market Restraint Analysis
3.3.1 Complications associated with Tumor Ablation therapy
3.3.2 Stringent regulations & approvals
3.4 Penetration & Growth Prospect Mapping: Product
3.5 Tumor Ablation Market c SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis – Porter’s

Chapter 4 Tumor Ablation Market: Technology Estimates & Trend Analysis
4.1 Tumor ablation market: Technology movement analysis
4.2 Radiofrequency ablation
4.3 Microwave ablation
4.4 Cryoablation
4.5 Irreversible electroporation
4.6 Other ablation technologies

Chapter 5 Tumor Ablation Market: Treatment Estimates & Trend Analysis
5.1 Tumor Ablation market: Treatment movement analysis
5.2 Surgical ablation
5.3 Laparoscopic ablation
5.4 Percutaneous ablation

Chapter 6 Tumor Ablation Market: Application Estimates & Trend Analysis
6.1 Tumor Ablation market: Application movement analysis
6.2 Liver cancer
6.3 Breast cancer
6.4 Lung cancer
6.5 Prostate cancer
6.6 Other cancer

Chapter 7 Market Share Analysis
7.1 Market share analysis: HIFU competitive analysis

Chapter 8 Regional Estimates & Trend Analysis, by Technology, Treatment, & Application
8.1 Tumor ablation market share by region, 2017 & 2025
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 Latin America
8.6 Middle East & Africa

Chapter 9 Competitive Landscape

9.1 Company Profiles9.1.1 Medtronic

9.1.2 AngioDynamics

9.1.3 Mermaid Medical

9.1.4 HealthTronics, Inc.

9.1.5 Galil Medical, Inc.

9.1.6 EDAP TMS

9.1.7 Boston Scientific Corporation

9.1.8 SonaCare Medical LLC

9.1.9 Misonix

9.1.10 NeuWave Medical, Inc.

9.1.11 ERBE Elektromedizin GmbH

9.1.12 Biotronik

For more information about this report visit

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:–expanding-at-a-cagr-of-11-12-300747434.html

©2017 PR Newswire. All Rights Reserved.